The microfluidic device to which ∼20 μL of samples containing 2 μL of serum...
The microfluidic device to which ∼20 μL of samples containing 2 μL of serum will be applied.

Source: Nishiyama K. et al., Sensors and Actuators B: Chemical. April 21, 2020

News • COVID-19 detection

New analyzer detects virus antibodies in 20 minutes

Researchers at Hokkaido University have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests.

If a suitable reagent is developed, this technology could be used to detect antibodies against SARS-CoV-2, the causative virus of COVID-19. 

The researchers published their findings in the journal Sensors and Actuators B: Chemical.

Avian influenza is a poultry disease caused by influenza A virus infection. Rapid initial response for a suspected infection and continuous surveillance are essential to mitigate the damage from highly pathogenic, transmittable pathogens such as avian influenza viruses. Generally, the polymerase chain reaction (PCR) method is used to detect the viral genome, but its complicated procedure requires a considerable amount of time. Another method involves detecting antibodies produced in the body in reaction to virus infection. However, widely used antibody detection methods can be inaccurate because the antibodies’ existence is generally determined by eyesight.

Photo
Professor Manabu Tokeshi (left) and the doctoral student Keine Nishiyama (right)
Source: Hokkaido University

The group, including Keine Nishiyama, a doctoral student at Hokkaido University’s Graduate School of Chemical Science and Engineering, and Professor Manabu Tokeshi of the university’s Faculty of Engineering, conducted this study to develop a new method and analyzer capable of rapid, facile and selective detection of antibodies. The method is based on conventional fluorescence polarization immunoassay (FPIA) but applies a different measurement mechanism to make the analyzer much smaller and portable. The analyzer weighs only 5.5 kilograms.

The combined use of liquid crystal molecules, an image sensor and the microfluidic device makes it possible to simultaneously examine multiple samples and reduces the volume of each sample required. Liquid crystal molecules are capable of controlling the polarization direction of fluorescent light, while the microfluidic device has a number of microchannels as a measurement vessel. The group also developed a reagent to detect anti-H5 avian influenza virus antibody, a fluorescein-labeled protein that binds only with the antibody. The reagent was made by reproducing hemagglutinin (HA) protein fragments, which are expressed on the surface of H5 avian influenza virus, through gene recombination and by labeling fluorescent molecules to the fragments.

Photo
An image obtained by the device and to be analyzed by the image analyzer. Samples show different degrees of polarization of light depending on the presence, absence, or the amount of anti-H5 avian influenza virus antibodies.
Source: Nishiyama K. et al., Sensors and Actuators B: Chemical. April 21, 2020

To make the measurement, serum collected from birds was mixed with the reagent and left for 15 minutes. The mixture was injected into the microfluidic device and measured with the portable fluorescence polarization analyzer. Molecular movements of the reagent bound with the antibody will be smaller in the liquid, producing a different degree of polarization from the reagent not bound with the antibody. The system can detect anti-H5 avian influenza virus antibody with only 2 microliters of serum sample and within 20 minutes. “Our analyzer could be used to conduct other bio tests if suitable reagents are developed,” says Tokeshi. The group has already successfully detected mycotoxin and drug constituents. “By reproducing fragments of spike proteins expressed in the novel coronavirus, and using them as the reagent, the analyzer should be able to detect anti-coronavirus antibodies.”


Source: Hokkaido University

25.05.2020

Read all latest stories

Related articles

Photo

Sponsored • Disease management

Multiplex Testing: A Solution to Manage Surge in Respiratory Illnesses as Concerns over “Multi-demic” Rise

Eunsin Bae, M.D. specializes in laboratory medicine and leads the Institute of Clinical Research at Seegene Inc. Her research focuses on microbiology, molecular biology, and hematology. Dr. Bae is…

Photo

Sponsored • POCT

Pluslife Biotech – Mini Dock POC Molecular System

The Pluslife Mini Dock System is a Next-Generation POC molecular diagnostic tool that can be used in different application scenarios, which aims to help the decentralization of MDx in diagnosing…

Photo

Sponsored • Diagnostics Alliance against SARS-CoV-2

The Global Alliance for Diagnostics Sets Next-Generation POC Molecular Testing Collaboration

The coronavirus pandemic is a huge challenge for global public health and welfare. Decentralized, affordable POC MDx platforms would allow more effective control of SARS-CoV-2 and other infections.

Related products

Sarstedt - COVID-19 virus diagnostics products

Saliva Collection

Sarstedt - COVID-19 virus diagnostics products

SARSTEDT AG & CO. KG
Beckman Coulter – AU5800 Series

Clinical Chemistry

Beckman Coulter – AU5800 Series

Beckman Coulter Diagnostics
Beckman Coulter – DxC 700 AU

Clincal Chemistry

Beckman Coulter – DxC 700 AU

Beckman Coulter Diagnostics
Beckman Coulter – DxH 690T

Blood Cell Counter

Beckman Coulter – DxH 690T

Beckman Coulter Diagnostics
Subscribe to Newsletter